Investor Presentaiton
OUR SOLUTIONS FOR BETTER CONTROL
0.37 mm
diameter
Nasdaq: ALIM
Designed to deliver
FAC for 36 months
Permeable membrane
of polyvinyl alcohol
Non-permeable cap
Nonbioerodable tube
of polyimide
Internal matrix containing 0.19 mg
of fluocinolone acetonide
3.5 mm length
FAc aqueous concentration, ng/mL
alimera
0.18 mg
ILUVIEN YUTIQ
(fluocinolone acetonide
intravitreal implant) 0.19mg
(fluocinolone acetonide
3.75
intravitreal implant) 0.18 mg
Delivers a Continuous, Therapeutic
Submicrogram Dose for Up to 36 Months (1)(2)
Aqueous Levels of FAC After Injecting ILUVIEN in Human
3.00
2.25
1.50
0.75
0
0 3 6 9
12
15
18
21
24 27 30 33
36
Months
NOTES:
(1) ILUVIEN® [package insert]. Alpharetta, GA: Alimera Sciences, Inc.
(2) Campochiaro PA, Nguyen QD, Hafiz G, et al. for the FAMOUS Study Group. These data were obtained using an assay validated for plasma
8View entire presentation